• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Microbiol Infect . Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observati

tetano

Editor, Senior Moderator
Clin Microbiol Infect


. 2020 Aug 18;S1198-743X(20)30493-6.
doi: 10.1016/j.cmi.2020.08.011. Online ahead of print.
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study


Irit Nachtigall[SUP] 1 [/SUP], Pavlina Lenga[SUP] 2 [/SUP], Katarzyna J?źwiak[SUP] 3 [/SUP], Petra Th?rmann[SUP] 4 [/SUP], Andreas Meier-Hellmann[SUP] 5 [/SUP], Ralf Kuhlen[SUP] 6 [/SUP], Joerg Brederlau[SUP] 7 [/SUP], Torsten Bauer[SUP] 8 [/SUP], Juergen Tebbenjohanns[SUP] 9 [/SUP], Karin Schwegmann[SUP] 10 [/SUP], Michael Hauptmann[SUP] 3 [/SUP], Julius Dengler[SUP] 11 [/SUP]



Affiliations

Abstract

Objectives: The coronavirus disease 2019 (COVID-19) pandemic situation in Germany is unique among large European countries in that incidence and case fatality rate are distinctly lower. We describe the clinical course and examine factors associated with outcomes among patients hospitalized with COVID-19 in Germany.
Methods: In this retrospective cohort study we included patients with COVID-19 admitted to a national network of German hospitals between February 12, and June 12, 2020. We examined demographic characteristics, comorbidities and clinical outcomes.
Results: We included 1904 patients with a median age of 73 years, and 48.5% (924/1904) were female. The mortality rate was 17% (317/1835; 95% confidence interval [CI] 16-19), the rate of admission to the intensive care unit (ICU) 21% (399/1860; 95% CI 20-23), and the rate of invasive mechanical ventilation 14% (250/1850: 95% CI 12-15). The most prominent risk factors for death were male sex (hazard ratio
1.45; 95% CI 1.2-1.8), preexisting lung disease (HR 1.61; 95% CI 1.20-2.16), and increased patient age (HR 4.1 [95% CI 2.6-6.6] for age >79 years versus <60 years). Among patients admitted to the ICU, the mortality rate was 29% (109/374; 95% CI 25-34) and higher in ventilated (33% [77/235; 95% CI 27-39]) than in non-ventilated ICU patients (23% [32/139; 95% CI 16-30]; p<0.05).
Conclusions: In this nationwide series of patients hospitalized with COVID-19 in Germany, in-hospital and ICU mortality rates were substantial. The most prominent risk factors for death were male sex, preexisting lung disease, and increased patient age.
 
Back
Top Bottom